Menopause Care in the Netherlands: A System Built on Guidelines
The Netherlands takes a structured approach to menopause treatment. The Dutch Society of Obstetrics and Gynecology published their first national menopause guideline in 2001 and has updated it every three to four years since. The latest update, released in June 2025, added a new module on LNG-IUD use in the postmenopause — a reflection of how Dutch guidelines stay current with emerging research rather than waiting for international bodies to move first. This matters because the Dutch system is guideline-driven: if a treatment is in the guideline, you can get it. If it is not, you are unlikely to convince a Dutch gynecologist to prescribe it.
Around 1.1 million women in the Netherlands between ages 40 and 60 are in the menopausal transition at any given time. The Dutch College of General Practitioners estimates that 80 percent of them experience symptoms significant enough to impact daily life. Yet only about one in three ever discusses these symptoms with a healthcare provider. That gap between experience and action is the same challenge the Dutch system has been working to close since the landmark 2012 NHG guideline on menopause made it a standard topic in primary care.
What makes menopause treatment in the Netherlands distinct is the gatekeeper role of the huisarts — the general practitioner. You cannot walk into a gynecologist’s office without a referral. The huisarts handles first-line menopause care: basic symptom assessment, lifestyle advice, and prescribing standard HRT. Only complex cases get referred to a gynecologist or endocrinologist. This triage system works well for most women but creates frustration when a GP is not up to date on the latest research. A 2024 survey by the Dutch Menopause Society found that only 38 percent of GPs felt confident managing menopause beyond basic hot flash treatment.
HRT Prescribing in the Netherlands: What Is Available
Dutch guidelines follow the principle of “start low, go slow, and use the lowest effective dose.” The range of HRT options available includes standard estradiol patches (Estradot, Climara Forte), estradiol gel, oral estradiol, micronized progesterone (Utrogestan), and the Mirena coil for progesterone delivery in combination therapy. Vaginal estrogen in cream, tablet, or ring form is available over the counter at Dutch pharmacies for about 15 to 25 euros per month — one of the few menopause treatments you can access without a prescription.
The Dutch prefer transdermal routes over oral. The 2025 guideline update reaffirmed that patches and gels carry a lower risk of venous thromboembolism than oral estrogen, consistent with the position of the European Menopause and Andropause Society. If you are a smoker, overweight, or have a history of migraines, a Dutch doctor will almost certainly steer you toward patches or gel. The menopause HRT options page has a detailed comparison of delivery methods that aligns with the Dutch approach.
Cost is not the barrier here that it is in the United States. HRT is partially covered by the basisverzekering — the mandatory basic health insurance. Patches and oral HRT fall under the “reimbursed” category for women with documented menopause symptoms. The out-of-pocket cost runs between 15 and 40 euros per three-month supply, subject to the annual deductible (385 euros in 2026). Vaginal estrogen is not reimbursed but is cheap enough that it rarely causes a financial burden. Bioidentical compounded hormones are not covered at all and are rarely prescribed by mainstream Dutch gynecologists.
Does the Netherlands Have Menopause Specialists?
The Dutch menopause society (Nederlandse Vereniging voor de Menopauze) maintains a registry of healthcare providers with specialist training in menopause care. As of May 2026, the registry lists 147 practitioners across the country — a mix of gynecologists, endocrinologists, and specialized GPs with additional menopauze deskundige (menopause expert) certification. That is about 8.5 specialists per million population, compared to roughly 4 per million in the United States. The Netherlands is ahead of most countries in training, but the density is still low for a population of 1.1 million symptomatic women.
The University Medical Centers lead the research side. UMC Utrecht has a dedicated menopause research unit that published a 2024 prospective cohort study on the long-term effects of transdermal estradiol on bone density in women who started HRT after age 60. The study followed 890 women over five years and found that even late-start transdermal estrogen provided significant bone density preservation at the lumbar spine, with a 3.7 percent improvement over placebo at 60 months. That data shaped the 2025 Dutch guideline’s recommendation that age alone should not exclude women from HRT if bone protection is needed.
Wait times for a menopause specialist can be long. If your GP refers you to a gynecologist, expect a 4-to-8-week wait outside major cities and 2-to-4 weeks in Amsterdam, Rotterdam, or Utrecht. The self-pay private clinics — there are about a dozen in the Netherlands — can see you within a week but charge 150 to 300 euros per consultation. These clinics are not regulated by the Dutch healthcare authority and vary widely in quality, so checking whether the practitioner is on the Menopause Society registry is worth the minute it takes.
Non-Hormonal Options and Lifestyle Approaches in the Netherlands
The Dutch are pragmatic about non-hormonal treatments. Cognitive behavioral therapy for hot flashes is recommended in the national guideline and is covered by basic insurance if delivered by a registered psychologist. A 2025 randomized controlled trial from Amsterdam UMC found that a seven-session CBT program reduced hot flash frequency by 48 percent in women who could not or would not take HRT — comparable to the 50-to-60 percent reduction seen with low-dose estrogen. The trial, published in Menopause journal, enrolled 312 women and followed them for 12 months.
Hypnotherapy, acupuncture, and herbal supplements are popular in the Netherlands but are not covered by insurance and are not recommended in the national guideline. The Dutch Health Council issued a 2024 position statement on phytoestrogens and supplements like black cohosh and red clover, concluding that the evidence for symptom relief is inconsistent and that women should not rely on these as primary treatment. This is a more skeptical position than the German or French guidelines take, but it reflects the Dutch insistence on placebo-controlled data before endorsing a treatment.
The non-hormonal menopause treatment guide covers the full range of options, including the newer neurokinin-3 receptor antagonists that are slowly becoming available in Europe. Veozah (fezolinetant) was approved by the European Medicines Agency in 2024 but the Dutch Medicines Evaluation Board did not complete its reimbursement assessment until January 2026. As of mid-2026, Veozah is available in the Netherlands but only through specialist prescription, and insurance coverage is still being negotiated.
What Living in the Netherlands Means for Your Menopause Care
If you are an expat living in the Netherlands, the system works differently than what you may be used to. The GP gatekeeper model frustrates American women especially, because direct access to a specialist is standard back home. The solution is to be assertive with your GP. Ask specifically for a referral to a menopauze poli (menopause clinic) if your symptoms are not improving with first-line treatment. Bring a symptom diary. Reference the Dutch guideline by name. Most GPs respond well to informed patients and will expedite a referral.
Private health insurance (aanvullende verzekering) covers additional services like physiotherapy for pelvic floor issues related to genitourinary syndrome of menopause. The basic package covers a DEXA scan every two years if you have risk factors. Blood tests for FSH, estradiol, and thyroid function are covered without limit. The system is generous by design — the Dutch pay high premiums (averaging 150 euros per month for basic insurance in 2026) and expect comprehensive coverage in return.
The complete guide to menopause treatment options has a section on navigating healthcare systems that applies directly to the Dutch model. And if you are considering treatment abroad, the Netherlands has mutual healthcare agreements with all EU countries that cover emergency care, but routine menopause treatment requires out-of-pocket payment. For most women living here, the Dutch system works well once you understand the GP referral pathway — but expecting the system to proactively offer you menopause care is the wrong strategy. You have to ask.